Company profile
Xtant Medical Holdings, Inc.
AMEX: XTNT · Healthcare · Medical - Devices
#323 of 1,418 Healthcare companies by revenue60th-percentile growth
EA Score
74BFH 79DQ 71GM 69SS 64
v0.1 · 65/100 weight · provisional
↑ Piotroski F, disclosure history · ↓ filing timeliness, market scale
Methodology →Revenue TTM
$121.9M
Rev growth YoY (TTM)
-0.3%
Net income (FY)
$5.0M
Employees
151
as of 2026-08-19
Market cap
$46.5M
as of 2026-08-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$133.9M$133.9M2025
Net income$5.0M$5.0M2025
Operating income$7.3M$7.3M2025
Total assets$94.1M$94.1M2025
Liabilities$43.2M$43.2M2025
Equity$51.0M$51.0M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Orthobiologics54%
Spinal Implant32%
License Revenue14%
By geography
UNITED STATES91%
Non-US9%
The read
What is Xtant Medical Holdings, Inc.’s revenue?
Xtant Medical Holdings, Inc. booked $133.9M in FY2025 revenue, growing 14% year over year — faster than most Healthcare companies we track, at a 3.7% net margin.
Peers · Healthcare
Telesis Bio, Inc.——National Research Corporation75B+RxSight, Inc.59CUpHealth, Inc.——Niagen Bioscience Inc78B+Xencor, Inc.59CNeighbors
Gallatin →Key facts
CEOSean E. Browne
SectorHealthcare
IndustryMedical - Devices
HeadquartersBelgrade, MT
ExchangeAMEX: XTNT
Employees151
IPO date2010-07-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.